Literature DB >> 31548328

IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells.

Yongzhong Wu1, Mariam M Konaté2, Jiamo Lu1, Hala Makhlouf2, Rodrigo Chuaqui2, Smitha Antony2, Jennifer L Meitzler1, Michael J Difilippantonio2, Han Liu2, Agnes Juhasz1, Guojian Jiang1, Iris Dahan2, Krishnendu Roy2, James H Doroshow3,2.   

Abstract

Dual oxidase 2 (DUOX2) generates H2O2 that plays a critical role in both host defense and chronic inflammation. Previously, we demonstrated that the proinflammatory mediators IFN-γ and LPS enhance expression of DUOX2 and its maturation factor DUOXA2 through STAT1- and NF-κB‒mediated signaling in human pancreatic cancer cells. Using a panel of colon and pancreatic cancer cell lines, we now report the induction of DUOX2/DUOXA2 mRNA and protein expression by the TH2 cytokine IL-4. IL-4 activated STAT6 signaling that, when silenced, significantly decreased induction of DUOX2. Furthermore, the TH17 cytokine IL-17A combined synergistically with IL-4 to increase DUOX2 expression in both colon and pancreatic cancer cells mediated, at least in part, by signaling through NF-κB. The upregulation of DUOX2 was associated with a significant increase in the production of extracellular H2O2 and DNA damage-as indicated by the accumulation of 8-oxo-dG and γH2AX-which was suppressed by the NADPH oxidase inhibitor diphenylene iodonium and a DUOX2-specific small interfering RNA. The clinical relevance of these experiments is suggested by immunohistochemical, microarray, and quantitative RT-PCR studies of human colon and pancreatic tumors demonstrating significantly higher DUOX2, IL-4R, and IL-17RA expression in tumors than in adjacent normal tissues; in pancreatic adenocarcinoma, increased DUOX2 expression is adversely associated with overall patient survival. These data suggest a functional association between DUOX2-mediated H2O2 production and induced DNA damage in gastrointestinal malignancies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31548328      PMCID: PMC6804760          DOI: 10.4049/jimmunol.1800469

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues.

Authors:  B Caillou; C Dupuy; L Lacroix; M Nocera; M Talbot; R Ohayon; D Dème; J M Bidart; M Schlumberger; A Virion
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

Review 2.  Interleukin-17 and type 17 helper T cells.

Authors:  Pierre Miossec; Thomas Korn; Vijay K Kuchroo
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

3.  Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma.

Authors:  Noriyoshi Fukushima; Jens Koopmann; Norihiro Sato; Nijaguna Prasad; Ralph Carvalho; Steven D Leach; Ralph H Hruban; Michael Goggins
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

Review 4.  Role of Nox family NADPH oxidases in host defense.

Authors:  Thomas L Leto; Miklos Geiszt
Journal:  Antioxid Redox Signal       Date:  2006 Sep-Oct       Impact factor: 8.401

Review 5.  Repair of oxidative DNA damage and cancer: recent progress in DNA base excision repair.

Authors:  Timothy L Scott; Suganya Rangaswamy; Christina A Wicker; Tadahide Izumi
Journal:  Antioxid Redox Signal       Date:  2013-10-15       Impact factor: 8.401

6.  Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation.

Authors:  Stanislas Morand; Takehiko Ueyama; Satoshi Tsujibe; Naoaki Saito; Agnieszka Korzeniowska; Thomas L Leto
Journal:  FASEB J       Date:  2008-12-12       Impact factor: 5.191

7.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

Review 8.  Untangling the complex web of IL-4- and IL-13-mediated signaling pathways.

Authors:  Marsha Wills-Karp; Fred D Finkelman
Journal:  Sci Signal       Date:  2008-12-23       Impact factor: 8.192

9.  Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense.

Authors:  Miklós Geiszt; Jassir Witta; Judit Baffi; Kristen Lekstrom; Thomas L Leto
Journal:  FASEB J       Date:  2003-06-03       Impact factor: 5.191

10.  Dual oxidase 2 and pancreatic adenocarcinoma: IFN-γ-mediated dual oxidase 2 overexpression results in H2O2-induced, ERK-associated up-regulation of HIF-1α and VEGF-A.

Authors:  Yongzhong Wu; Jennifer L Meitzler; Smitha Antony; Agnes Juhasz; Jiamo Lu; Guojian Jiang; Han Liu; Melinda Hollingshead; Diana C Haines; Donna Butcher; Michaela S Panter; Krishnendu Roy; James H Doroshow
Journal:  Oncotarget       Date:  2016-10-18
View more
  10 in total

1.  DUOX2 participates in skin aging induced by UVB in HSF2 cells by activating NF-κB signaling.

Authors:  Xiaoqing Xiao; Minghuan Huang; Chunyan Fan; Fuguo Zuo
Journal:  Exp Ther Med       Date:  2020-12-17       Impact factor: 2.447

2.  Inhibiting the Activity of NADPH Oxidase in Cancer.

Authors:  Mariam M Konaté; Smitha Antony; James H Doroshow
Journal:  Antioxid Redox Signal       Date:  2020-04-17       Impact factor: 8.401

3.  DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.

Authors:  Meng Cao; Peng-Bo Zhang; Peng-Fei Wu; Qun Chen; Wan-Li Ge; Guo-Dong Shi; Jie Yin; Bao-Bao Cai; Shou-Ji Cao; Yi Miao; Kui-Rong Jiang
Journal:  Biomed Res Int       Date:  2021-03-02       Impact factor: 3.411

Review 4.  The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses.

Authors:  Reyes Gamez-Belmonte; Lena Erkert; Stefan Wirtz; Christoph Becker
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

5.  Loss of Interleukin-13-Receptor-Alpha-1 Induces Apoptosis and Promotes EMT in Pancreatic Cancer.

Authors:  Jingwei Shi; Xiao Shen; Qi Kang; Xing Yang; Maximilian Denzinger; Marko Kornmann; Benno Traub
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

6.  ZhenQi FuZheng formula inhibits the growth of colorectal tumors by modulating intestinal microflora-mediated immune function.

Authors:  Weiqi Meng; Zhiping Li; Yiting Zhang; Anhui Yang; Yanzhen Wang; Yulin Zhou; Wanyue Wu; Ye Qiu; Lanzhou Li
Journal:  Aging (Albany NY)       Date:  2022-06-08       Impact factor: 5.955

7.  Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study.

Authors:  Qihan Luo; Shuo Huang; Lisha Zhao; Jingqun Liu; Qing Ma; Yiheng Wang; Yu Dong; Changyu Li; Ping Qiu
Journal:  Front Pharmacol       Date:  2022-08-03       Impact factor: 5.988

Review 8.  Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation.

Authors:  Chris M Li; Zhibin Chen
Journal:  Front Cell Dev Biol       Date:  2021-06-21

Review 9.  Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer.

Authors:  Jingwei Shi; Xujun Song; Benno Traub; Michael Luxenhofer; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

Review 10.  Macrophages, as a Promising Strategy to Targeted Treatment for Colorectal Cancer Metastasis in Tumor Immune Microenvironment.

Authors:  Yingru Zhang; Yiyang Zhao; Qi Li; Yan Wang
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.